Vaxart, Inc.

VXRTOTC· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$237.3M

▲ 726.7% YoY

Net Income

$16.3M

▲ 124.4% YoY

EPS

$0.07

▲ 121.2% YoY

Cash

$63.8M

▲ 152.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.